SCI Abstract

search
+
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Evaluating the predictive value of another hepatocellular carcinoma tumor marker, protein induced by vitamin K absence/ant...
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study
This study compares ICI-based therapy with TACE in a real-world postoperative setting and to assess whether extended ICI t...
P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE
P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE
Evaluate the Assessment for Retreatment with TACE score in predicting survival after trans-arterial chemoembolization in h...
The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma
The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma
This study screened 12 members of the let-7 family & their related lncRNAs. We then selected targets that have predict...
Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma
Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma
Evaluating clinical efficacy of postoperative adjuvant transarterial chemoembolization in cytokeratin 19-positive hepatoce...
Spontaneous Rupture of Hepatocellular Carcinoma: Pathogenesis, Clinical Management, Prognostic Factors, and Future Directions
Spontaneous Rupture of Hepatocellular Carcinoma: Pathogenesis, Clinical Management, Prognostic Factors, and Future Directions
By integrating available data and highlighting unresolved questions, we hope to guide clinical practice and inform the des...
Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway
Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway
In the study, we provided novel insights into the mechanism of CMSS1 in HCC progression.
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative Review
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative Review
Nuclear medicine holds potential for identifying patients who are likely to benefit from targeted and immunotherapy.
Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model
Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model
This study shows that preoperative hepatic steatosis is an independent risk factor for postoperative recurrence in HBV-rel...
ANT Score Nomogram for Predicting Very Early Recurrence of Hepatocellular Carcinoma
ANT Score Nomogram for Predicting Very Early Recurrence of Hepatocellular Carcinoma
we developed and validated the ANT Score, a novel prognostic model that integrates nutrition, inflammation, and tumor burd...
Low Aggregate Index of Systemic Inflammation Values Correlate with Favorable Prognosis and High Abundance of Parabacteroides in Hepatocellular Carcinoma
Low Aggregate Index of Systemic Inflammation Values Correlate with Favorable Prognosis and High Abundance of Parabacteroides in Hepatocellular Carcinoma
Prognostic significance of systemic inflammation in hepatocellular carcinoma and potential mechanisms via gut microbiota a...
Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation
Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation
Suggesting that the most impactful risk factors for early recurrence are aggressive tumor features including tumor size, n...
Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?
Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?
Investigating the clinical characteristics of adolescent PLC by integrating multi-center clinical data and conducting comp...
sCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma
sCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma
To evaluate the relationship between soluble CD36 & type 2 diabetes mellitus complicated by hepatocellular carcinoma, ...
ARID3A Promotes Tumor Progression by Activating TNF-α/NF-κB Signaling in Dual-Phenotype Hepatocellular Carcinoma
ARID3A Promotes Tumor Progression by Activating TNF-α/NF-κB Signaling in Dual-Phenotype Hepatocellular Carcinoma
Our study reveals that ARID3A acts as an oncogene and promotes aggressive features of stem-like cells in DPHCC via the ARI...
Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma
Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma
Study aimed to identify genes associated with transarterial chemoembolization refractoriness and their roles in hepatocell...
CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy
CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy
To construct a radiomics-based model for predicting postoperative recurrence in HCC patients with VETC positive based on C...
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Re...
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
This study uses real-world data to compare the effectiveness & safety of lenvatinib & sorafenib, addressing gaps b...
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
We aimed to conduct a comprehensive survival analysis of OS and progression-free survival (PFS) for patients with unresect...
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
this study evaluates changes in SMI after TACE-MTAs-ICIs treatment, and to analyze the association of reversal of SMI with...
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Evaluating the efficacy and safety of TACE combined with HAIC plus lenvatinib for intermediate-stage HCC beyond up-to-seve...
A Case of DEB-TACE Combined with Anlotinib for Treatment of Liver Metastasis from Retroperitoneal Leiomyosarcoma
A Case of DEB-TACE Combined with Anlotinib for Treatment of Liver Metastasis from Retroperitoneal Leiomyosarcoma
Reporting a case with multiple liver metastases from retroperitoneal leiomyosarcoma, confirmed by postoperative pathology,...
Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells
Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells
The aim of this study is to investigate the recurrence and progression of liver cancer by focusing on the energy metabolis...
Prognostic Value of Changes in Combined Child–Pugh Class and ALBI Grade in Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Plus Targeted Therapy and PD-(L)1 Inhibitors
Prognostic Value of Changes in Combined Child–Pugh Class and ALBI Grade in Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Plus Targeted Therapy and PD-(L)1 Inhibitors
Liver function changes in HCC patients treated with combined treatment and prognostic significance of combination Child&nd...
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention Targets
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention Targets
Review focusing on the clinical and research assessment of patient-reported outcomes among patients with hepatocellular ca...
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer
Identifying novel biomarkers to improve the diagnostic ability of PLC.
Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study
Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study
To explore the safety and efficacy of dual immunotherapy in later-line Hepatocellular Carcinoma treatment.
Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma
Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma
This retrospective study used the Lasso-Cox approach to identify predictors of early recurrence in post-resection HCC pati...
Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience
Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience
Describing the clinical outcomes of Radiation Segmentectomy and External Beam Radiation Therapy for treatment-naïve, ...
Load More
format_indent_increase